Founder of 5 different companies, notably: Kura Oncology, Inc., Avidity Biosciences, Inc. and Ambrx, Inc. Troy E. Wilson is an entrepreneur and businessperson who has been the head of 9 different companies and is Non-Executive Chairman of Avidity Biosciences, Inc. (which he founded in 2012), Chairman, President & Chief Executive Officer at Kura Oncology, Inc. (which he founded in 2014), Executive Chairman at Wellspring Biosciences LLC and Executive Chairman at Abintus Bio, Inc. Troy E. Wilson is also on the board of Puma Biotechnology, Inc. and Managing Member at Araxes Pharma LLC.
He previously was President for Wildcat Discovery Technologies, Inc. (he founded the company), Chief Business Officer for Ambrx, Inc. (he founded the company in 2003), Founding Partner of Presidio Partners, Chairman, President & Chief Executive Officer of Zeta Acquisition Corp. III, President, Chief Executive Officer & Director at Intellikine LLC (he founded the company in 2007), Chief Executive Officer of Takeda Pharmaceuticals U.S.A., Inc. and Vice President-Business Development of Novartis Institute for Functional Genomics, Inc.
Troy E. Wilson received an undergraduate degree and a doctorate from the University of California, Berkeley and a graduate degree from New York University.